Back to Search
Start Over
Venous thromboembolism in patients with heart failure: in-hospital and chronic use of anti-coagulants for prevention
- Source :
- Recent patents on cardiovascular drug discovery. 7(1)
- Publication Year :
- 2011
-
Abstract
- Heart failure (HF) is a common clinical syndrome characterized by high morbidity and frequent hospitalizations. HF is an independent and major risk factor for venous thromboembolism (VTE) and VTE occurring in patients with HF carries a worse prognosis. The present review will focus on short and long term role of anti-coagulants in prevention of venous thrombosis in HF patients. We will also be discussing the recently investigated and patented anti-coagulants which could have a role in this specific population.
- Subjects :
- Heart Failure
medicine.medical_specialty
business.industry
Anticoagulants
Venous Thromboembolism
medicine.disease
Venous thrombosis
High morbidity
Risk Factors
Heart failure
Drug Discovery
medicine
Humans
Pharmacology (medical)
In patient
Risk factor
Anti-coagulants
Cardiology and Cardiovascular Medicine
business
Intensive care medicine
Clinical syndrome
Venous thromboembolism
Randomized Controlled Trials as Topic
Subjects
Details
- Volume :
- 7
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Recent patents on cardiovascular drug discovery
- Accession number :
- edsair.doi.dedup.....becad7ad0594e35f0f2e31e146fa58d3